New York Life Invest Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

New York Life Invest, the investment management arm of the historic New York Life Insurance Company, represents a sophisticated archetype of institutional capital management. As of the first quarter of 2026, the institution manages a reported portfolio value of approximately $11.82 billion. This scale places it among the significant "tier-one" institutional players, though it operates with a distinct philosophy that blends the fiduciary prudence of an insurance-backed entity with the aggressive growth pursuit required in modern equity markets. The current portfolio snapshot reveals a highly complex and diversified structure, comprising 781 individual stocks and exchange-traded funds. This sheer number of holdings immediately signals a "multi-strategy" or "core-satellite" approach, where the institution likely manages a variety of internal sub-funds, client mandates, and strategic asset allocation models simultaneously.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

The overwhelming allocation to Technology reflects a profound macro judgment: that the "Artificial Intelligence Revolution" has moved from a speculative phase into a structural implementation phase. By dedicating a third of its capital to this space, the institution is signaling that it expects productivity gains from AI, semiconductor advancement, and software-as-a-service (SaaS) to outpace the broader economy. This is not a passive holding; the internal movements within the technology sector—shifting toward R&D leaders—suggest a search for "quality growth" rather than just "growth at any price."

Based on this sector layout, we can infer that New York Life Invest is operating under an "Optimistic but Selective" macro framework. The heavy tech tilt suggests they do not foresee a looming recession that would derail growth stocks. However, the diversified presence in Financials and Industrials suggests they are prepared for a "no-landing" or "soft-landing" scenario where economic activity remains robust enough to support cyclical earnings. The institution is essentially betting on a bifurcated market where innovation leads, but traditional economic pillars provide the necessary foundation for a multi-billion dollar portfolio.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

The logic behind this addition likely stems from NVIDIA's evolving business model, moving from a pure hardware provider to a full-stack AI platform. By adding to the position at a reported price of $174 (post-split adjusted or 2026 valuation levels), the institution is betting on the "Sovereign AI" trend and the continued expansion of data center capital expenditures by cloud service providers. Interestingly, while the share count rose, the portfolio weight actually ticked down slightly from 5.44% to 5.24%. This suggests that the broader portfolio grew faster or that other positions were aggressively scaled, but it also reflects a disciplined approach to "weight management"—ensuring that no single stock becomes an unmanageable risk to the total $11.8 billion fund.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

In the 2026 market context, this move suggests a belief that the "low-hanging fruit" of the AI rally has been picked, and the next winners will be those who are reinvesting most aggressively in the next generation of technologies—be it quantum computing, advanced biotech, or next-gen energy. This is a highly offensive move that significantly increases the portfolio's "innovation beta." It also demonstrates the institution's commitment to its internal "Candriam" and "MacKay" research frameworks, using its own products to express its highest-conviction thematic views.

The total estimated buy scale across these top additions exceeds $350 million. When compared to the sales (discussed in the next section), it is clear that New York Life Invest is in a "net buying" or "reallocation" mode. They are taking capital out of defensive fixed-income-like ETFs and specific underperforming cyclical stocks to fund this aggressive expansion into innovation. This move increases the overall "offensiveness" of the portfolio, suggesting that the institution's leadership is bullish on the medium-term prospects of the equity market.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

In the institutional world, holding short-term treasuries is a way to park cash while waiting for opportunities. By selling nearly $30 million of this position, New York Life Invest is signaling that the "waiting period" is over. They are moving capital out of the safety of government bonds and into the volatility of the equity market (specifically the R&D and Mid-Cap ETFs mentioned in Section IV). This is a clear "Risk-On" indicator; the institution is more afraid of missing the next leg of the equity rally than it is of market volatility.

The $18.85 million reduction in the NYLI Winslow Large Cap Growth ETF (-15.81%) is a "Strategy Rotation" play. It might seem contradictory to sell a growth ETF while buying tech stocks, but the logic lies in the type of growth. The Winslow ETF likely focuses on traditional, large-cap "steady" growth. By reducing this and buying the "R&D Leaders" (ETF-LRND) and "Mid Cap" (ETF-IQSM) funds, the institution is shifting from "Passive/Traditional Growth" to "Thematic/Aggressive Growth." It is a refinement of their growth factor, moving away from what they might perceive as "crowded" large-cap growth trades into more specialized areas.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

For individual investors, the reference value here is the "Institutional Confidence in Market Breadth." The move into mid-caps and R&D leaders suggests that the "smart money" believes the rally is sustainable and will expand beyond the top few names. However, the institution's reliance on its own internal ETFs also serves as a reminder that they have access to granular research and factor-based models that the average investor does not. Their "buy" is not just a buy on a ticker, but a buy on a specific, researched investment factor.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.